CD79A and cancer: In our study, we collected more serological inflammation markers to evaluate the prognostic value for predicting OTSCC patients’ survival, such as IgG, IgA, IgM, C3, C4 and BF, all of which played an important role in development and progression of cancer, and might have potential prognostic value for cancer patient’s survival prediction [49–56].